Hodgkin Lymphoma News and Research

RSS
Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

Allos Therapeutics' FOLOTYN data to be presented at 46th ASCO and 15th EHA Congress

Poor survival rates in non-Hodgkin's lymphoma patients attributed to lifestyle factors

Poor survival rates in non-Hodgkin's lymphoma patients attributed to lifestyle factors

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Updates on Micromet's BiTE antibody development programs to be made at two medical conferences

Data on retreatment experiences with brentuximab vedotin in clinical trials to be presented at 2010 ASCO

Data on retreatment experiences with brentuximab vedotin in clinical trials to be presented at 2010 ASCO

Phase III PRIMA study data of Rituxan to be featured at 46th ASCO

Phase III PRIMA study data of Rituxan to be featured at 46th ASCO

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Cell Therapeutics reports cardiac safety results from phase II trial of pixantrone in CHOP-R regimen

Biovest International announces filing of proposed Plan of Reorganization

Biovest International announces filing of proposed Plan of Reorganization

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

Smoking, obesity and alcohol use associated with poorer survival of non-Hodgkin's lymphoma patients

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

CTI to conduct phase II study of pixantrone in patients with HER2-negative breast cancer

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Researchers develop new type of drug to kill non-Hodgkin lymphoma tumor cells

Immunomedics third-quarter revenues increase to $10.7 million

Immunomedics third-quarter revenues increase to $10.7 million

Ancient DNA sequences within human cells can help cancer cells survive: Study

Ancient DNA sequences within human cells can help cancer cells survive: Study

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures

Research roundup: Managing nursing home patients, streamlining medical billing, financial disclosures

Researchers discover a new driving force behind cancer growth

Researchers discover a new driving force behind cancer growth

Immunogen reports a net loss of $12.1 million in third quarter 2010

Immunogen reports a net loss of $12.1 million in third quarter 2010

Cancer-related expenditures increase faster than any other area of health care: JAMA

Cancer-related expenditures increase faster than any other area of health care: JAMA

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

CTI receives positive reception from EMEA clinical experts for pixantrone MAA

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Seattle Genetics reports revenues of $46.5M for first-quarter 2010

Myths and facts about pediatric cancer

Myths and facts about pediatric cancer

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

Immunomedics reports on ribonuclease-based immunotoxin development at AACR meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.